$0.07
(5.91%)
Add to watchlist
Create an alert
Stocks and Shares ISAStandard BioTools Inc. has a portfolio of technologies that help biomedical researchers develop medicines faster. The Company develops, manufactures and sells a diversified range of instrumentation, consumables, and services. The Company's Genomics business includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. Its Biomark X9 system for high-throughput genomics delivers scalability for qPCR applications. Designed for researchers who require robust multiplexing capabilities, the Biomark X9 system enables the simultaneous analysis of thousands of reactions in a single run. By leveraging advanced microfluidics technology, it reduces reagent consumption while increasing throughput, making it a solution for large-scale genomic studies, clinical research, and biomarker discovery. The Biomark X9 system integrates with data analysis tools, accelerating workflows and providing comprehensive insights.
Company Information
About this company
Key people
Michael Egholm
President, Chief Executive Officer, Director
Hanjoon Alex Kim
Chief Financial Officer
Sean Mackay
Chief Business Officer
Thomas Carey
Independent Chairman of the Board
Eli D. Casdin
Independent Director
Troy Cox
Independent Director
Fenel M. Eloi
Independent Director
Kathy Hibbs
Independent Director
Click to see more
Key facts
- Shares in issue403.15m
- EPICLAB
- ISINUS34385P1084
- LocationUnited States
- SectorTechnology
- IndustryScientific & Technical Instr.
- Market cap$423.02m
- Employees818
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.